BML, Inc. (MUN:BMZ)

Market Cap	767.38M
Revenue (ttm)	884.69M
Net Income (ttm)	38.70M
Shares Out	n/a
EPS (ttm)	0.99
PE Ratio	19.83
Forward PE	n/a
Dividend	0.74 (3.81%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	15
Open	19.20
Previous Close	19.40
Day's Range	19.20 - 19.20
52-Week Range	16.00 - 20.00
Beta	n/a
RSI	63.35
Earnings Date	Aug 8, 2025

About BML, Inc.

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from...

• Industry: Commercial Physical and Biological Research
• Founded: 1955
• Employees: 4,558
• Stock Exchange: Munich Stock Exchange
• Ticker Symbol: BMZ

Financial Performance

In 2024, BML, Inc.'s revenue was 143.19 billion, an increase of 3.79% compared to the previous year's 137.96 billion. Earnings were 6.26 billion, an increase of 3.80%.

Financial numbers in JPY